Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Achieving clinical equality in an influenza pandemic: patent realities.

Kane EM.

Seton Hall Law Rev. 2009;39(4):1137-72.

PMID:
20718133
2.

Influenza a (H1N1) outbreak and challenges for pharmacotherapy.

Chawla R, Sharma RK, Bhardwaj JR.

Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):113-26. Review.

PMID:
20112815
3.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
4.

Avian influenza: a review.

Thomas JK, Noppenberger J.

Am J Health Syst Pharm. 2007 Jan 15;64(2):149-65. Review.

PMID:
17215466
5.

Pandemic influenza: overview of vaccines and antiviral drugs.

Cox MM.

Yale J Biol Med. 2005 Oct;78(5):321-8. Review.

6.

Preventing avian influenza in humans: the role of simple public health interventions.

Bhatia R, Narain JP.

Southeast Asian J Trop Med Public Health. 2006 Nov;37(6):1229-36. Review.

PMID:
17333782
8.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

PMID:
18948744
9.
10.

[Influenza, an existing public health problem].

García-García J, Ramos C.

Salud Publica Mex. 2006 May-Jun;48(3):244-67. Review. Spanish.

11.

Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.

Sym D, Patel PN, El-Chaar GM.

Ann Pharmacother. 2009 Dec;43(12):2001-11. doi: 10.1345/aph.1M557. Epub 2009 Nov 17. Review.

PMID:
19920156
12.

Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.

Abelin A, Colegate T, Gardner S, Hehme N, Palache A.

Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27. Review.

13.

An influenza A H1N1 virus revival - pandemic H1N1/09 virus.

Michaelis M, Doerr HW, Cinatl J Jr.

Infection. 2009 Oct;37(5):381-9. doi: 10.1007/s15010-009-9181-5. Epub 2009 Sep 18. Review.

PMID:
19768379
14.

[Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update].

Loulergue P, Launay O.

Med Sci (Paris). 2009 Aug-Sep;25(8-9):719-25. doi: 10.1051/medsci/2009258-9719. Review. French.

15.

2009 pandemic influenza: a review.

Faruqui F, Mukundan D.

Curr Opin Pediatr. 2010 Aug;22(4):530-5. doi: 10.1097/MOP.0b013e32833bb81a. Review.

PMID:
20601883
16.

Vaccines against epidemic and pandemic influenza.

Hoelscher M, Gangappa S, Zhong W, Jayashankar L, Sambhara S.

Expert Opin Drug Deliv. 2008 Oct;5(10):1139-57. doi: 10.1517/17425247.5.10.1139 . Review. Erratum in: Expert Opin Drug Deliv. 2009 Feb;6(2):209.

PMID:
18817518
17.

Antiviral drugs for the control of pandemic influenza virus.

Sugrue RJ, Tan BH, Yeo DS, Sutejo R.

Ann Acad Med Singapore. 2008 Jun;37(6):518-24. Review.

18.

Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.

Ford SM, Grabenstein JD.

Pharmacotherapy. 2006 Mar;26(3):312-22. Review.

PMID:
16503711
19.

Influenza vaccines: the good, the bad, and the eggs.

Schultz-Cherry S, Jones JC.

Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Review.

PMID:
20951870
20.

An update on swine-origin influenza virus A/H1N1: a review.

Schnitzler SU, Schnitzler P.

Virus Genes. 2009 Dec;39(3):279-92. doi: 10.1007/s11262-009-0404-8. Epub 2009 Oct 7. Review.

PMID:
19809872

Supplemental Content

Support Center